Hanley Jr. Michael Conick 4
4 · Aeglea BioTherapeutics, Inc. · Filed Oct 23, 2019
Insider Transaction Report
Form 4
Hanley Jr. Michael Conick
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-10-21+130,000→ 130,000 totalExercise: $7.79Exp: 2029-10-20→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]The options will vest as to 1/4th of the total shares on October 21, 2020, and then 1/48th of the shares monthly thereafter, such that the option is fully vested on October 21, 2023, subject to the Reporting Person's provision of service to the issuer on each vesting date.